aXichem’s CEO Torsten Helsing Participates at Stora Aktiedagarna in Stockholm, 28 November 2024
aXichem AB (publ), announces that the company's CEO, Torsten Helsing, will participate at Aktiespararna's event Stora Aktiedagarna in Stockholm, on November 28, 2024. The event will be webcasted live at this link
https://invitepeople.com/public/events/ade744dfee/pages/ad355f8861
aXichem’s presentation starts at 14:20. Please note that the presentation will be in Swedish.
Stora Aktiedagarna takes place at Birger Jarl Conference, Birger Jarlsgatan 61 A in Stockholm.
The information was submitted, through the care of the contact person below, for publication on
25 November 2024, at 13:00 CET.
Company contact:
Torsten Helsing, CEO, aXichem AB
Phone: +46 706 863 355 Email: [email protected]
About aXichem
aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio- enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB.
More information is available at www.axichem.com.